Status:
UNKNOWN
Hear Me Read 2021 Clinical Trial
Lead Sponsor:
Prasanth Pattisapu
Collaborating Sponsors:
Clinical and Translational Intramural Funding Program from the Abigail Wexner Research Institute
Conditions:
Hearing Loss
Deafness
Eligibility:
All Genders
3-5 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate if the effects of in-person speech-language therapy with a novel digital storybook intervention platform (Hear Me Read) improves vocabulary, speech and languag...
Detailed Description
For this study, 50 children, who are deaf/hard of hearing, and their caregiver will be enrolled into 2 separate 6-month intervention periods, for a total of 12 months of participation. There are two i...
Eligibility Criteria
Inclusion
- Male and female children ages 3.0-5.11 (5 years and 11 months) at time of initial assessment and:
- Bilateral Sensorineural or mixed hearing loss at least (PTA≥30dB)
- Auditory neuropathy in both ears
Exclusion
- English not primary language
- Standard score CLS \>2 SD from normal on CELF-P3
Key Trial Info
Start Date :
March 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05245799
Start Date
March 25 2022
End Date
December 31 2024
Last Update
March 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationwide Children's Hospital
Columbus, Ohio, United States, 43205